Made infamous as the club drug Special K, ketamine is nowadays being seen as a wonder drug for some folks with hard-to-treat depression. However, a new study finds that some types of patients are more likely to gain a rapid and significant benefit from ketamine than others. Overall, while most patients did benefit from the drug, about one-third experienced a “rapid improvement” in their depression symptoms, the researchers said. Certain patient characteristics appeared to predict that level of benefit. “Severely depressed individuals with a history of childhood trauma may have a better likelihood of a rapid and robust response to ketamine,” concluded lead researcher Brittany O’Brien, an assistant professor of psychiatry and behavioral sciences at Baylor College of Medicine in Houston. In 2019, the U.S. Food and Drug Administration approved a ketamine derivative called esketamine (Spravato) for depression that has failed to respond to at least two conventional antidepressants. Given as a nasal spray, esketamine is different from ketamine, which is an injectable anesthetic that can have mind-altering effects. The new study included nearly 300 people with major depression who were treated with three infusions of ketamine at an outpatient clinic. Participants were 40 years old, on average, and most were men. They had not responded to at least two antidepressants in the past. Mood changes were measured using a standardized depression scale over six… read on > read on >

















